Microbot Medical Inc. (MBOT)
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Last price
- $0.69
- As of
Kresmion compiles this page from MBOT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Microbot Medical Inc. (MBOT): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-16.
See the full MBOT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MBOT on one page. Preview it with sample data, then open it live with a free account.
Preview the MBOT dossierActive events for MBOT
- high13F: large reduction
CITADEL ADVISORS LLC cut 75% of MBOT (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 81% of MBOT (2026Q2)
- high13F: large increase
MILLENNIUM MANAGEMENT LLC added +872% to MBOT (2026Q1)
- mediumEarnings below estimates
Q3-2025: Missed consensus by 14.4% - EPS $-0.07 vs $-0.0612 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 22.5% - EPS $-0.1 vs $-0.0816 estimate
FREE, NO ACCOUNT
Every event on MBOT, as it fires
You are seeing 5 of 8 events recorded on MBOT since 2026-06-02.
The five above landed across 4 days. The other 3 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, MBOT
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
More data on MBOT
MBOT against its peers
MBOT's return on equity of -16.9% ranks in the 62nd percentile of 19 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | MBOT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 31.5M | n/a | 19 |
| Gross margin | n/a | 57.7% | n/a | 19 |
| Operating margin | n/a | -55.3% | n/a | 19 |
| Net margin | n/a | -48.1% | n/a | 20 |
| Return on equity | -16.9% | -59.4% | 63 | 19 |
| 1 year | -66.4% | -24.7% | 17 | 20 |
Peers (22): POCI, STXS, NYXH, HBIO, NEPH, MLSS, KRMD, NNNN, UTMD, PDEX, OSUR, RVP, BNGO, SMTI, CUPR, FEMY, EMBC, UEEC, RGNT, ZJYL, AVR, LUCY. Left out: DXR (no annual filing), ZTEKF (no annual filing), DAVI (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (MBOT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in MBOT on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on MBOT in the last 180 days.
Upstream: SEC EDGAR filings for MBOT
Kresmion, "Microbot Medical Inc. (MBOT) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/MBOT. Upstream data: SEC EDGAR filings for MBOT.
Link to this data (HTML):
<a href="https://kresmion.com/research/MBOT">Microbot Medical Inc. (MBOT) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow MBOT on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to MBOT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.